Atlas Trials

Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer

Clinical trial NCT01871363 · UNKNOWN

Trial details

NCT number
NCT01871363
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Malignant Neoplasm
Start date
2012-10-01
Primary completion
2015-10-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.